XOMA (US) LLC

Type: Company
Name: XOMA (US) LLC
First reported 11 hours ago - Updated 6 hours ago - 1 reports

Puma Biotechnology: Another Jackpot For Investors

Investors who purchased shares in Puma Biotechnology Inc. before the closing of Wall Street on Tuesday—at around $60 or better at the 52-week low of $33.70 — hit the jackpot.The stock was trading north of $230 on Wednesday, an overnight gain of  293% ... [Published Forbes.com - 11 hours ago]
First reported Jul 18 2014 - Updated Jul 18 2014 - 1 reports

Insider Selling: XOMA Corp CEO Unloads 10,000 Shares of Stock (XOMA)

XOMA Corp (NASDAQ:XOMA) CEO John Varian sold 10,000 shares of XOMA Corp stock in a transaction dated Tuesday, July 15th. The stock was sold at an average price of $4.03, for a total value of $40,300.00. Following the completion of the sale, the chief ... [Published American Banking News - Jul 18 2014]
First reported Jul 10 2014 - Updated Jul 11 2014 - 1 reports

Pre-market Equity Watch on Biotech Industry -- Research on Halozyme

Therapeutics, XOMA, Amicus Therapeutics, and Arena Pharma07/10 06:20 CDT Therapeutics, XOMA, Amicus Therapeutics, and Arena PharmaEditor Note: For more information about this release, please scroll to bottom. LONDON, July 10, 2014LONDON, July 10, 2014 ... [Published Finwin - Jul 10 2014]
First reported Jul 03 2014 - Updated Jul 03 2014 - 1 reports

Insider Selling: XOMA Corp VP Sells 5,000 Shares of Stock (XOMA)

XOMA Corp (NASDAQ:XOMA) VP Patrick J. Md Phd Scannon unloaded 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, July 1st. The stock was sold at an average price of $4.68, for a total transaction of $23,400.00. Following the ... [Published American Banking News - Jul 03 2014]
First reported Jul 02 2014 - Updated Jul 02 2014 - 1 reports

4 Biotech Stocks Under $10 to Watch for Breakout Trades

DELAFIELD, Wis. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percentage losers.>> 5 Stocks Set to Soar on Bullish EarningsStocks that are making large moves like these ... [Published Litchfield County Times - Jul 02 2014]
First reported Jul 02 2014 - Updated Jul 02 2014 - 1 reports

4 Biotech Stocks Under $10 to Watch for Breakout Trades

DELAFIELD, Wis. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percentage losers. >>5 Stocks Set to Soar on Bullish EarningsStocks that are making large moves like these ... [Published The Street Latest - Jul 02 2014]
First reported Jul 01 2014 - Updated Jul 01 2014 - 1 reports

XOMA (US) LLC Call Today At 4:30pm ET/1:30pm PT To Confirm Communication Plan For EYEGUARD®-B Clinical Program

7/1/2014 10:24:13 AMBERKELEY, Calif., June 30, 2014 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced the Company will host a conference call today, Monday, June 30, 2014, ... [Published BioSpace - Jul 01 2014]
First reported Jun 27 2014 - Updated Jun 27 2014 - 2 reports

The FDA Approval Process: Overview, Pros, Cons, and its Effect on Share Prices; Analyst Report by BrokerBank Securities, Inc.

PR NewswireNEW YORK, June 27, 2014NEW YORKNew drugs cover a large range and include those that are not based on existing medications, are made by a different manufacturer, use different inactive ingredients, are used for a different purpose, or undergo ... [Published Digital Journal - Jun 27 2014]
First reported Jun 25 2014 - Updated Jun 25 2014 - 1 reports

Biotech Funding Deals and Partnerships 2014: Analysis of 56 Recent Venture Capital and Corporate Capital Funding and Other Transactions

Research and Markets (http://www.researchandmarkets.com/research/r6b8dm/biotech_funding) has announced the addition of the "Biotech Funding Deals and Partnerships: Analysis of Recent Venture Capital and Corporate Capital Funding and Other Transactions" ... [Published Individual.com - Jun 25 2014]
First reported Jun 19 2014 - Updated Jun 19 2014 - 1 reports

Insider Selling: Paul D. Rubin Unloads 11,580 Shares of XOMA Corp Stock (XOMA)

XOMA Corp (NASDAQ:XOMA) CMO Paul D. Rubin sold 11,580 shares of XOMA Corp stock on the open market in a transaction that occurred on Monday, June 16th. The stock was sold at an average price of $4.54, for a total transaction of $52,573.20. Following the ... [Published American Banking News - Jun 19 2014]
First reported Jun 13 2014 - Updated Jun 13 2014 - 1 reports

3 Stocks Under $10 in Breakout Territory

DELAFIELD, Wis. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percentage losers. >>5 Stocks Insiders Love Right NowStocks that are making large moves like these are favorites ... [Published The Street Latest - Jun 13 2014]
First reported Mar 05 2014 - Updated Mar 05 2014 - 2 reports

Why XOMA Corporation (XOMA) Is Plunging Today

NEW YORK (TheStreet) -- XOMA Corporation  was plunging 25% to $7.08 at 10:26 a.m. on Wednesday after the biotechnology company announced that it would not move forward with late-stage testing of its drug gevokizumab as a treatment for a form of arthritis ... [Published The Street Latest - Mar 05 2014]

Quotes

"In the second quarter, we demonstrated that we can generate significant revenue"
"This global Phase 3 study in children and adults with LAL Deficiency builds upon our earlier insights into both the manifestations of the disease and the impact of sebelipase alfa. The results from this controlled trial demonstrate the effects of sebelipase alfa on a broad range of disease-related abnormalities and are consistent with the ability of enzyme replacement therapy to address the root cause of the disease. We look forward to providing further details of the study at a future medical conference" said Anthony Quinn, MBChB, PhD, FRCP, Executive Vice President and Chief Medical Officer at Synageva
Research and Markets (http://www.researchandmarkets.com/research/r6b8dm/biotech_funding) has announced the addition of the "Biotech Funding Deals and Partnerships: Analysis of Recent Venture Capital and Corporate Capital Funding and Other Transactions" report to their offering. Nearly one out of every 8 dollars invested in companies are invested in biotech...
* A new report says that Canadian residential real estate has been getting a huge boost from so-called echo boomers, those in the 20-38 age bracket. "The Baby Boom generation grabs most of the attention on this front, but their children, the echo boomers, pack a heavy economic punch as well." Bank of Montreal economist Robert Kavcic, said in a report released on Thursday. ( http://r.reuters.com/saz99v )

More Content

All (51) | News (29) | Reports (0) | Blogs (7) | Audio/Video (0) | Fact Sheets (1) | Press Releases (14)
sort by: Date | Relevance
BioInvent Interim Report 1 January – 30 June 2014 [Published NASDAQ OMX - 12 mins ago]
Puma Biotechnology: Another Jackpot For Investors [Published Forbes.com - 11 hours ago]
Global Type 1 Diabetes Market 2014-2018: Key Ve... [Published Myrtle Beach Sun News - Jul 18 2014]
Insider Selling: XOMA Corp CEO Unloads 10,000 S... [Published American Banking News - Jul 18 2014]
H5N1 Infection (Avian Influenza) - Pipeline Rev... [Published Individual.com - Jul 15 2014]
Pre-market Equity Watch on Biotech Industry -- ... [Published Finwin - Jul 10 2014]
Pre-market Equity Watch on Biotech Industry -- ... [Published Financial Services - Jul 10 2014]
Ingersoll-Rand Finds Escaping U.S. Tax No Penal... [Published Accounting Today - Jul 08 2014]
Global hypertension drugs market will grow at a... [Published Live-PR.com - Jul 08 2014]
Insider Selling: XOMA Corp VP Sells 5,000 Share... [Published American Banking News - Jul 03 2014]
4 Biotech Stocks Under $10 to Watch for Breakou... [Published Litchfield County Times - Jul 02 2014]
4 Biotech Stocks Under $10 to Watch for Breakou... [Published The Street Latest - Jul 02 2014]
XOMA (US) LLC Call Today At 4:30pm ET/1:30pm PT... [Published BioSpace - Jul 01 2014]
FDA Approves MannKind's Afrezza; Synageva BioPh... [Published BioMedReports - Jul 01 2014]
XOMA Call Today at 4:30pm ET/1:30pm PT to Confi... [Published GlobeNewswire: Acquisitions News - Jun 30 2014]
Antibody formulations [Published PharmCast - Jun 29 2014]
The FDA Approval Process: Overview, Pros, Cons,... [Published Digital Journal - Jun 27 2014]
The FDA Approval Process: Overview, Pros, Cons,... [Published Michigan Live - Jun 27 2014]
Global Hypertension Drugs Market 2014-2018 [Published Individual.com - Jun 26 2014]
Biotech Funding Deals and Partnerships 2014: An... [Published Individual.com - Jun 25 2014]
The High-Flier Stocks Are Back [Published Bloomberg - Jun 20 2014]
Insider Selling: Paul D. Rubin Unloads 11,580 S... [Published American Banking News - Jun 19 2014]
ReportsnReports.com: 2018 Worldwide Type 1 Diab... [Published BusinessWeek - Jun 17 2014]
US EQUITIES OPENING HEADLINES INCLUDING: US equ... [Published Proactiveinvestors United Kingdom RSS feed - Jun 13 2014]
Frontrunning: June 13 [Published Zero Hedge - Jun 13 2014]
3 Stocks Under $10 in Breakout Territory [Published The Street Latest - Jun 13 2014]
Acne Vulgaris Market Opportunity Analysis and F... [Published PRWeb - Jun 11 2014]
Health Care Sector Stocks Highlight -- Research... [Published Financial Services - Jun 02 2014]
XOMA to Present at the Jefferies Global Healthc... [Published GlobeNewswire: Acquisitions News - May 28 2014]
5 Stocks Under $10 Set to Soar [Published The Street Latest - May 22 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Frontrunning: June 13 [Published Zero Hedge - Jun 13 2014]
Tea Party struggles to repeat Cantor-style shock in Tennessee ( Reuters ) Iran Deploys Forces to Fight al Qaeda-Inspired Militants in Iraq ( WSJ ) Oil Rallies as Militant Advance in Iraq Threatens Crude ( BBG ) Gold Set for First Back-to-Back Weekly Gain ...
Frontrunning: May 8 [Published Zero Hedge - May 08 2014]
China’s Trade Unexpectedly Rises ( BBG ) 'We're already not in Ukraine' - rebel east readies secession vote ( Reuters ) Pro-Russian Separatists in Ukraine Reject Putin's Call to Delay Vote ( WSJ ) Hedge Funds Extend Their Slide ( WSJ ) Carney Looks to ...
Xoma to stop testing drug as arthritis treatmen... [Published Yahoo! Health News - Mar 05 2014]
United States drug developer Xoma Corp said it would not proceed with late-stage studies of its lead drug, an antibody called gevokizumab, as a treatment for a form of arthritis of the hand after two mid-stage studies showed the drug was not effec... ...
XOMA Suffers Big Setback [Published Wall St. Cheat Sheet - Mar 05 2014]
While many biotechnology stocks have been generating impressive returns of late, one stock suffered a major setback on Tuesday evening. That company is XOMA Corporation ( NASDAQ:XOMA ). XOMA Corporation is a biotechnology company focused on the ...
Frontrunning: March 5 [Published Zero Hedge - Mar 05 2014]
High Stakes Limit Bid to Cow Putin ( WSJ ) Russia says can't control Crimea troops ahead of U.S. talks ( Reuters ) Crimea Crisis Haunted by Ghosts of Bungled World War I Diplomacy ( BBG ) Putin’s Ukraine Gambit Hurts Economy as Allies Lose Billions  ( ...
1 2

Press Releases

sort by: Date | Relevance
Pre-market Equity Watch on Biotech Industry -- ... [Published Financial Services - Jul 10 2014]
XOMA Call Today at 4:30pm ET/1:30pm PT to Confi... [Published GlobeNewswire: Acquisitions News - Jun 30 2014]
Health Care Sector Stocks Highlight -- Research... [Published Financial Services - Jun 02 2014]
XOMA to Present at the Jefferies Global Healthc... [Published GlobeNewswire: Acquisitions News - May 28 2014]
XOMA to Present at the Bank of America Merrill ... [Published GlobeNewswire: Acquisitions News - May 12 2014]
1 2 3
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.